Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: Association of Bcl-2 expression with hormone receptor status

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 10, 1998, Pages 895-902

  Usuki, Jiro ^a   Horiba, Koji ^a   Chu, Shan C ^a   Moss, Joel ^a   Ferrans, Victor J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR; MYC PROTEIN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN MCL 1; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHANGIOLEIOMYOMATOSIS; PROTEIN EXPRESSION;

ADULT; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LUNG NEOPLASMS; LYMPHANGIOMYOMA; MIDDLE AGED; MITOSIS; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CELL SURFACE; STAINING AND LABELING;

EID: 0031792469     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kitaichi M, Nishimura K, Itoh H, et al. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995;151:527-533.
2. Taylor JR, Ryu J, Colby TV, et al. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med. 1990;323:1254-1260.
3. Corrin B, Liebow AA, Friedman PJ. Pulmonary lymphangiomyomatosis: a review. Am J Pathol. 1975;79:348-382.
4. Kapur RP, Bigler SA, Skelly M, et al. Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem. 1992;40:207-212.
5. Berger U, Khaghani A, Pomerance A, et al. Pulmonary lymphangioleiomyomatosis and steroid receptors: an immunocytochemical study. Am J Clin Pathol. 1990;93:609-614.
6. Colley MH, Geppert E, Franklin WA. Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis. Am J Surg Pathol. 1989;13:803-807.
7. Brentani MM, Carvalho CR, Saldiva PH, et al. Steroid receptors in pulmonary lymphangiomyomatosis. Chest. 1984;85:96-99.
8. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6.
9. Tsujimoto Y, Gorham J, Cossman J, et al. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science. 1985;229:1390-1393.
10. Lu QL, Poulsom R, Wong L, et al. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol. 1993;169:431-437.
11. LeBrun DP, Warnke RA, Clearly ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol. 1993;142:743-753.
12. Hockenbery DM, Zutter M, Hickey W, et al. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A. 1991;88:6961-6965.
13. Compel A, Sabourin JC, Martin A, et al. Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol. 1994;144:1195-1202.
14. Kozopas KM, Yang T, Buchan HL, et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci U S A. 1993;90:3516-3520.
15. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993; 74:609-619.
16. Lu QL, Abel P, Foster CS, et al. bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 1996;27:102-110.
17. Sedlak TW, Oltvai ZN, Yang E, et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci U S A. 1995;92: 7834-7838.
18. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax [see comments]. Nature. 1994;369:321-323.
19. Esteban JM, Battifora H, Warsi Z, et al. Quantification of estrogen receptors on paraffin-embedded tumors by image analysis. Mod Pathol. 1991;4:53-57.
20. Brambilla E, Negoescu A, Gazzeri S, et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol. 1996;149:1941-1952.
21. Krajewski S, Bodrug S, Krajewska M, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol. 1995;146:1309-1319.
22. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 beta-converting enzyme [see comments]. Am J Pathol. 1995;147:251-266.
23. Joensuu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol. 1994;145:1191-1198.
24. Bhargava V, Kell DL, van de Rijn M, et al. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol. 1994;145: 535-540.
25. Teixeira C, Reed JC, Pratt MA. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 1995;55:3902-3907.
26. McDonnell TJ, Troncoso P, Brisbay SM, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992;52:6940-6944.
27. Matsuo H, Maruo T, Samoto T. Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. J Clin Endocrinol Metab. 1997;82:293-299.
28. Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med. 1981;154:1899-1909.
29. Yu CC, Filipe MI. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J. 1993;25:843-853.
30. Bissonnette RP, Echeverri F, Mahboubi A, et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 1992;359:552-554.
31. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature. 1992;359:554-556.
32. Alarcon RM, Rupnow BA, Graeber TG, et al. Modulation of c-Myc activity and apoptosis in vivo. Cancer Res. 1996;56:4315-4319.
33. Royds JA, Sharrard RM, Wagner B, et al. Cellular localisation of c-myc product in human colorectal epithelial neoplasia. J Pathol. 1992;166:225-233.
34. Loke SL, Neckers LM, Schwab G, et al. c-myc protein in normal tissue: effects of fixation on its apparent subcellular distribution. Am J Pathol. 1988;131: 29-37.
35. Santos GF, Scott GK, Lee WM, et al. Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem. 1988;263;9565-9568.